Autoimmune Lung Center and Interstitial Lung Disease Program, National Jewish Health, 1400 Jackson Street, Denver, Colorado 80206, USA.
Health Qual Life Outcomes. 2010 Jul 31;8:77. doi: 10.1186/1477-7525-8-77.
There is no disease-specific instrument to assess health-related quality of life (HRQL) in patients with idiopathic pulmonary fibrosis (IPF).
Patients' perspectives were collected to develop domains and items for an IPF-specific HRQL instrument. We used item variance and Rasch analysis to construct the ATAQ-IPF (A Tool to Assess Quality of life in IPF).
The ATAQ-IPF version 1 is composed of 74 items comprising 13 domains. All items fit the Rasch model. Domains and the total instrument possess acceptable psychometric characteristics for a multidimensional questionnaire. The pattern of correlations between ATAQ-IPF scores and physiologic variables known to be important in IPF, along with significant differences in ATAQ-IPF scores between subjects using versus those not using supplemental oxygen, support its validity.
Patient-centered and careful statistical methodologies were used to construct the ATAQ-IPF version 1, an IPF-specific HRQL instrument. Simple summation scoring is used to derive individual domain scores as well as a total score. Results support the validity of the ATAQ-IPF, and future studies will build on that validity.
目前尚无专门针对特发性肺纤维化(IPF)患者的疾病特异性工具来评估健康相关生活质量(HRQL)。
我们收集了患者的观点,以开发专门用于 IPF 的 HRQL 工具的领域和项目。我们使用项目方差和 Rasch 分析来构建 ATAQ-IPF(用于评估 IPF 患者生活质量的工具)。
ATAQ-IPF 版本 1 由 74 个项目组成,包含 13 个领域。所有项目均符合 Rasch 模型。领域和总仪器对多维问卷具有可接受的心理测量特性。ATAQ-IPF 评分与已知对 IPF 很重要的生理变量之间的相关性模式,以及使用与不使用补充氧气的受试者之间的 ATAQ-IPF 评分存在显著差异,支持其有效性。
使用以患者为中心和仔细的统计方法构建了 ATAQ-IPF 版本 1,这是一种专门针对 IPF 的 HRQL 工具。使用简单的总和评分来得出各个领域的评分以及总分。结果支持 ATAQ-IPF 的有效性,未来的研究将在此基础上进一步验证。